One Opana ER settlement

Actavis announced the deal yesterday. Per this settlement, Actavis will launch the product "on or after July 15, 2011, and earlier under certain circumstances."

Stay tuned for Impax, Barr, Sandoz etc.

Sandoz biogeneric and Rochej's China push

Todays news:

1. Sandoz received EU approval of Filgrastim
2. Per Chinese media, Roche is actively seeking in-licensing an NCE from China.

Merck's Biogeneric Move

After announcing its ambition in biogenerics, Merck today announced acquiring Insmed. Insmed has been testing water for quite some time with news of GCSF study and engaing RBC etc.

New PIVs

Based on brand companies announcement, PIVs have been filed for Tarceva and Cubicin.

Teva filed both PIVs.

News today

1. Lundbeck buys Ovation for $800M and $300M milestones.
2. Fosrenol PIV filers are Myland and Barr per Shire announcement.

None

"Tomorrow is a new day. You'll always have a chance to win it back." ~~Ari Gold

GSK may acquire Piramal

Per WSJ report today. The price tag is $1.5B.

FTC challenges Androgel deal

Watson and Par sued for their settlements with Solvay. It sure took a while for FTC.